Parkinson’s disease (PD) is a neurodegenerative disorder pathologically distinguished by
degeneration of dopaminergic neurons in the substantia nigra pars compacta. Muscle rigidity, …

… in medical history for James Parkinson's by addition of more symptoms to … Parkinson's
disease (PD) for those symptoms [4]. Being the second most familiar ND after Alzheimer's disease …

… Pathophysiology of Parkinson disease: Factors influencing the development of … of novel
therapeutic approaches and challenges associated with the current anti-Parkinson drug therapy …

… In this review, we will focus on α- Synuclein, LRRK2, and GBA-targeted therapies, as
they offer the most promising short-term prospects and are the furthest advanced in clinical …

… In summary, no actual therapy prevents the progression of the disease or regenerates the
SNpc. Therefore, therapeutic strategies that prevent loss of DAn or compensate neuronal …

… Application of nanomaterials in stem cell therapy of Parkinson’s disease. Preoperative …
addressing the limitations of cell-based therapy for Parkinson’s disease. Moreover, “intelligent” …

… of Parkinson's disease pathogenesis … Parkinson's disease that are also aberrant in
sporadic cases. From this finding emerges a key concept regarding whether Parkinson's disease …

… In this review, we will discuss the prospects and challenges of hPSC-based cell therapy for
… Comparison of potential cell sources for cell replacement therapy for Parkinson’s disease (PD…

… by the availability of multiple highly efficacious symptomatic therapies, which in their
different combinations offer a prospect of extended periods of satisfactory symptom control for a …

… Mitochondrial dysfunctions in neurodegenerative diseases: role in disease pathogenesis,
strategies for analysis and therapeutic prospects : Neural Regeneration Research …